Footnotes

• X @mcgouveia_, @marianascarant1

• MCG and THMdS contributed equally.

• Contributors Study concept: MS. Drafting of the commentary: MCG, THMS. Critical revision of the commentary: MS.

• Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

• Competing interests MCG: Speaker fees: Novartis, Knight Therapeutics. THMS has no competing interests to declare. MS: Speaker fees and/or honoraria for consulting or advisory functions: MSD, AstraZeneca, Libbs, GSK, Zodiac, Roche, Orentt, MDHealth, Sanofi, Gilead, Amgen, Sophia genetics.

• Provenance and peer review Not commissioned; internally peer reviewed.